Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S,50S)-23-((1H-imidazol-5-yl)methyl)-50-amino-8-(2-amino-2-oxoethyl)-35-(3-amino-3-oxopropyl)-41-(4-aminobutyl)-11,32-dibenzyl-38,44-bis(2-carboxyethyl)-47-(carboxymethyl)-26-(4-hydroxybenzyl)-14-(hydroxymethyl)-17,20,29-triisobutyl-2-isopropyl-5-methyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49-hexadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-hexadecaazadopentacontane-1,52-dioic acid
ID: ALA4635206
Chembl Id: CHEMBL4635206
PubChem CID: 156014625
Max Phase: Preclinical
Molecular Formula: C95H138N22O30
Molecular Weight: 2068.27
Molecule Type: Unknown
Associated Items: